Care Providers vs. Feds and Research Establishment: Its Getting Nastier
The TrialSite reported on the recent Ford Health System findings based on an observational study that hydroxychloroquine cuts the COVID-19 […]
5
Hydroxychloroquine Politicization Continues as Ohio Board of Pharmacy Bans Drug & Then Rescinds
Only in the age of COVID-19 have drugs become so politicized. For example, the story of Hydroxychloroquine: drug that was […]
4
Not a ‘Knockout Drug’ But Knocking it Out of the Ballpark: Gilead Windfall as Remdesivir COVID-19 Sales to Hit $1 to $3 billion in 2020
Although Gilead’s recent quarterly results were worse than expected, one strong ray of light was remdesivir thanks to the fact […]
1
WHO Solidarity Trial Discontinues Use of Hydroxychloroquine & Lopinavir/Ritonavir for Hospitalized COVID-19 Patients
The World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine […]
1
More Evidence for Hydroxychloroquine as a Life-Saver; CNN Casts Doubts
As we reported July 3, a Henry Ford Health System retrospective found a significant reduction in death for those treated […]
10